Literature DB >> 25307419

8/8 and 10/10 high-resolution match rate for the be the match unrelated donor registry.

Jason Dehn1, Kelly Buck2, Martin Maiers2, Dennis Confer2, Robert Hartzman3, Craig Kollman4, Alexander H Schmidt5, Soo Young Yang6, Michelle Setterholm2.   

Abstract

The National Marrow Donor Program's Be The Match Registry(®) facilitates the worldwide utilization of unrelated donor (URD) grafts for patients in need of a hematopoietic cell transplantation. In this study, we estimate the URD match rate for patients of White (WH), Hispanic (HIS), Asian/Pacific Islander (API), and African American/Black (AFA) race and ethnic groups. We chose 1344 URD at random as "pseudo-patients" (PP) to estimate the likelihood of finding an 8/8 or 10/10 high-resolution HLA-A,-B,-C,-DRB1 (and -DQB1) matched URD. Searches were conducted in the Be The Match Registry database for each PP at 2 time points: 2009 and 2012. URD who were a potential match for a PP by low/intermediate resolution were HLA typed by sequence-based typing to resolve the matching status. The 8/8 match rate for WH PP improved from 68% in 2009 to 72% in 2012. Corresponding match rates were 41% to 44% for HIS, 44% to 46% for API, and 27% to 30% for AFA, for 2009 and 2012, respectively. The 2012 10/10 match rates were 67% for WH, 38% for HIS, 41% for API, and 23% for AFA. These results provide baseline 8/8 and 10/10 match rate estimates by race for patients seeking an URD.
Copyright © 2015 American Society for Blood and Marrow Transplantation. All rights reserved.

Entities:  

Keywords:  Allogeneic; Donor registry; HLA matching; Marrow and stem cell transplantation; Racial disparity

Mesh:

Substances:

Year:  2014        PMID: 25307419     DOI: 10.1016/j.bbmt.2014.10.002

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  15 in total

1.  Unrelated donor search prognostic score to support early HLA consultation and clinical decisions.

Authors:  K Wadsworth; M Albrecht; R Fonstad; S Spellman; M Maiers; J Dehn
Journal:  Bone Marrow Transplant       Date:  2016-06-06       Impact factor: 5.483

2.  Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide.

Authors:  Shannon R McCurdy; Jennifer A Kanakry; Margaret M Showel; Hua-Ling Tsai; Javier Bolaños-Meade; Gary L Rosner; Christopher G Kanakry; Karlo Perica; Heather J Symons; Robert A Brodsky; Douglas E Gladstone; Carol Ann Huff; Keith W Pratz; Gabrielle T Prince; Amy E Dezern; Ivana Gojo; William H Matsui; Ivan Borrello; Michael A McDevitt; Lode J Swinnen; B Douglas Smith; Mark J Levis; Richard F Ambinder; Leo Luznik; Richard J Jones; Ephraim J Fuchs; Yvette L Kasamon
Journal:  Blood       Date:  2015-03-26       Impact factor: 22.113

Review 3.  Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017!

Authors:  Tamila L Kindwall-Keller; Karen K Ballen
Journal:  Oncologist       Date:  2017-05-25

4.  Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial.

Authors:  Javier Bolaños-Meade; Kenneth R Cooke; Christopher J Gamper; Syed Abbas Ali; Richard F Ambinder; Ivan M Borrello; Ephraim J Fuchs; Douglas E Gladstone; Christian B Gocke; Carol Ann Huff; Leo Luznik; Lode J Swinnen; Heather J Symons; Stephanie A Terezakis; Nina Wagner-Johnston; Richard J Jones; Robert A Brodsky
Journal:  Lancet Haematol       Date:  2019-03-14       Impact factor: 18.959

5.  Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis.

Authors:  Juliet N Barker; Kirsten Boughan; Parastoo B Dahi; Sean M Devlin; Molly A Maloy; Kristine Naputo; Christopher M Mazis; Eric Davis; Melissa Nhaissi; Deborah Wells; Candice Cooper; Doris M Ponce; Nancy Kernan; Andromachi Scaradavou; Sergio A Giralt; Esperanza B Papadopoulos; Ioannis Politikos
Journal:  Blood Adv       Date:  2019-04-09

6.  Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial.

Authors:  Amy E DeZern; Mary Eapen; Juan Wu; Julie-An Talano; Melhem Solh; Blachy J Dávila Saldaña; Chatchada Karanes; Mitchell E Horwitz; Kanwaldeep Mallhi; Sally Arai; Nosha Farhadfar; Elizabeth Hexner; Peter Westervelt; Joseph H Antin; H Joachim Deeg; Eric Leifer; Robert A Brodsky; Brent R Logan; Mary M Horowitz; Richard J Jones; Michael A Pulsipher
Journal:  Lancet Haematol       Date:  2022-07-27       Impact factor: 30.153

7.  The increase of the global donor inventory is of limited benefit to patients of non-Northwestern European descent.

Authors:  Suzanna M van Walraven; Anneke Brand; Jack N A Bakker; Martin B A Heemskerk; Suzan Nillesen; Marc B Bierings; Laura B Bungener; Bouke G Hepkema; Arjan Lankester; Arnold van der Meer; Kees Sintnicolaas; Judith A E Somers; Eric Spierings; Marcel G J Tilanus; Christien E M Voorter; Jan J Cornelissen; Machteld Oudshoorn
Journal:  Haematologica       Date:  2016-08-25       Impact factor: 9.941

Review 8.  Which factors influence the development of GVHD in HLA-matched or mismatched transplants?

Authors:  Effie W Petersdorf
Journal:  Best Pract Res Clin Haematol       Date:  2017-09-22       Impact factor: 3.020

9.  Simulation shows that HLA-matched stem cell donors can remain unidentified in donor searches.

Authors:  Jürgen Sauter; Ute V Solloch; Anette S Giani; Jan A Hofmann; Alexander H Schmidt
Journal:  Sci Rep       Date:  2016-02-15       Impact factor: 4.379

10.  Likelihood of Proceeding to Allogeneic Hematopoietic Cell Transplantation in the United States after Search Activation in the National Registry: Impact of Patient Age, Disease, and Search Prognosis.

Authors:  Jason Dehn; Pintip Chitphakdithai; Bronwen E Shaw; Abby A McDonald; Steven M Devine; Linda J Burns; Stephen Spellman
Journal:  Transplant Cell Ther       Date:  2020-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.